Similar articles for PMID: 15154115

Year	Number of Results
2000	1
2001	5
2002	3
2003	4
2004	8
2005	4
2006	7
2007	13
2008	7
2009	15
2010	6
2011	5
2012	5
2013	4
2014	4
2015	12
2016	6
2017	6
2018	5
2019	7
2020	2
2021	4
2022	1
2023	2
2024	0

1

Long-term safety and efficacy of enzyme replacement therapy for Fabry disease.

Wilcox WR, Banikazemi M, Guffon N, Waldek S, Lee P, Linthorst GE, Desnick RJ, Germain DP; International Fabry Disease Study Group. Wilcox WR, et al. Am J Hum Genet. 2004 Jul;75(1):65-74. doi: 10.1086/422366. Epub 2004 May 20. Am J Hum Genet. 2004. PMID: 15154115 Free PMC article. Clinical Trial.

2

Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.

Germain DP, Waldek S, Banikazemi M, Bushinsky DA, Charrow J, Desnick RJ, Lee P, Loew T, Vedder AC, Abichandani R, Wilcox WR, Guffon N. Germain DP, et al. J Am Soc Nephrol. 2007 May;18(5):1547-57. doi: 10.1681/ASN.2006080816. Epub 2007 Apr 4. J Am Soc Nephrol. 2007. PMID: 17409312 Clinical Trial.

3

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.

Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ; International Collaborative Fabry Disease Study Group. Eng CM, et al. N Engl J Med. 2001 Jul 5;345(1):9-16. doi: 10.1056/NEJM200107053450102. N Engl J Med. 2001. PMID: 11439963 Free article. Clinical Trial.

4

A retrospective analysis of the potential impact of IgG antibodies to agalsidase beta on efficacy during enzyme replacement therapy for Fabry disease.

Bénichou B, Goyal S, Sung C, Norfleet AM, O'Brien F. Bénichou B, et al. Mol Genet Metab. 2009 Jan;96(1):4-12. doi: 10.1016/j.ymgme.2008.10.004. Epub 2008 Nov 20. Mol Genet Metab. 2009. PMID: 19022694 Clinical Trial.

5

Monitoring the 3-year efficacy of enzyme replacement therapy in fabry disease by repeated skin biopsies.

Thurberg BL, Randolph Byers H, Granter SR, Phelps RG, Gordon RE, O'Callaghan M. Thurberg BL, et al. J Invest Dermatol. 2004 Apr;122(4):900-8. doi: 10.1111/j.0022-202X.2004.22425.x. J Invest Dermatol. 2004. PMID: 15102080 Free article. Clinical Trial.

6

Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial.

Ramaswami U, Bichet DG, Clarke LA, Dostalova G, Fainboim A, Fellgiebel A, Forcelini CM, An Haack K, Hopkin RJ, Mauer M, Najafian B, Scott CR, Shankar SP, Thurberg BL, Tøndel C, Tylki-Szymanska A, Bénichou B, Wijburg FA. Ramaswami U, et al. Mol Genet Metab. 2019 May;127(1):86-94. doi: 10.1016/j.ymgme.2019.03.010. Epub 2019 Apr 3. Mol Genet Metab. 2019. PMID: 30987917 Free article. Clinical Trial.

7

Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease.

Lubanda JC, Anijalg E, Bzdúch V, Thurberg BL, Bénichou B, Tylki-Szymanska A. Lubanda JC, et al. Genet Med. 2009 Apr;11(4):256-64. doi: 10.1097/GIM.0b013e3181981d82. Genet Med. 2009. PMID: 19265719 Free article. Clinical Trial.

8

Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease.

Wraith JE, Tylki-Szymanska A, Guffon N, Lien YH, Tsimaratos M, Vellodi A, Germain DP. Wraith JE, et al. J Pediatr. 2008 Apr;152(4):563-70, 570.e1. doi: 10.1016/j.jpeds.2007.09.007. Epub 2007 Dec 3. J Pediatr. 2008. PMID: 18346516 Clinical Trial.

9

Enzyme replacement therapy in Japanese Fabry disease patients: the results of a phase 2 bridging study.

Eto Y, Ohashi T, Utsunomiya Y, Fujiwara M, Mizuno A, Inui K, Sakai N, Kitagawa T, Suzuki Y, Mochizuki S, Kawakami M, Hosoya T, Owada M, Sakuraba H, Saito H. Eto Y, et al. J Inherit Metab Dis. 2005;28(4):575-83. doi: 10.1007/s10545-005-0575-y. J Inherit Metab Dis. 2005. PMID: 15902561 Clinical Trial.

10

Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy.

Thurberg BL, Fallon JT, Mitchell R, Aretz T, Gordon RE, O'Callaghan MW. Thurberg BL, et al. Circulation. 2009 May 19;119(19):2561-7. doi: 10.1161/CIRCULATIONAHA.108.841494. Epub 2009 May 4. Circulation. 2009. PMID: 19414635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

115 results

Results by year